The breast reconstruction market provides various implant-based and tissue expansion-based reconstructive procedures to restore breast shape and size after mastectomy or breast cancer treatment. With technological advancements, breast implants are becoming more natural in appearance and feel while being safer, durable, and adjustable implants for breast cancer patients. The breast implants available today mimic the soft texture of breast tissue and have a more natural silhouette, providing confidence and completion to women after surgery.
The global breast reconstruction market is estimated to be valued at US$ 2.1 Bn in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the breast reconstruction market are Polytech Health & Aesthetics GmbH, Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra Inc., GC Aesthetics, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe.
The key opportunities in the market include significant breast reconstruction volume in developing countries with growing focus on aesthetics, and partnerships and collaborations between medical technology companies and hospitals to increase breast reconstruction rate.
Technological advancements like 3D printing technology for customized implants and tissue-engineered breast reconstruction will play an important role in improving outcomes and driving the market growth over the forecast period.
Market Drivers
Growing incidence of breast cancer is a leading cause for increasing breast reconstruction procedures globally. According to the World Cancer Research Fund (WCRF) International, breast cancer is the most commonly occurring cancer in women worldwide, with an estimated 2.3 million new cases diagnosed in 2020. This rising breast cancer prevalence is expected to surge the demand for breast reconstruction surgeries in the coming years, thereby driving market growth.
Current Challenges in Breast Reconstruction Market:
The breast reconstruction market is facing many challenges which include lack of breast specialists which is hindering the growth of this market. Insufficient reimbursement policies for breast reconstruction procedures is also a big challenge. High cost of breast reconstruction surgeries is also restricting many patients to opt for these procedures. Lack of awareness among women especially in developing countries regarding breast reconstruction options after mastectomy is another challenge for this industry. Additionally, complications associated with breast implants like capsular contracture is also challenging the growth of this market.
SWOT Analysis
Strength: Dominant players having strong product portfolio and recognized brands; growing breast cancer cases driving the demand.
Weakness: High cost of surgeries restricting market growth; lack of specialists in developing regions.
Opportunity: Untapped markets in developing countries; technological advancements bringing new reconstruction options.
Threats: Risk of complications; stringent regulations can delay new product approvals.
Geographical Regions
North America captured over 40% of global breast reconstruction market share in terms of value in 2020 due to high rates of breast cancer surgeries and growing awareness in the region. Major players based in the US also supplements the regional growth.
Asia Pacific is expected to be the fastest growing regional market during the forecast period mainly driven by developing countries like China and India. Growing medical tourism and rising breast cancer cases are supporting the market expansion in Asia Pacific.
